Summary
Characteristics probably associated with the fetal hormonal milieu have recently been shown to increase (birth size indicators, prematurity, neonatal jaundice) or decrease (pregnancy toxaemia) breast cancer risk in the female offspring. However, it is unknown whether differences in pregnancy hormone levels may contribute to the marked geographical variation in breast cancer incidence. We have compared, in a highly standardized manner, pregnancy hormone levels in a population with high incidence and one with low incidence of breast cancer. Three hundred and four pregnant Caucasian women in Boston and 334 pregnant Chinese women in Shanghai were enrolled from March 1994 to October 1995. Levels of oestradiol, oestriol, prolactin, progesterone, human growth hormone, albumin and sex hormone-binding globulin were measured in maternal blood at weeks 16 and 27 of gestation and compared between the two study sites using non-parametric Wilcoxon’s rank-sum test. Demographical, anthropometrical and pregnancy characteristics were ascertained through interview, and relevant variables concerning delivery and the newborn were abstracted from medical records and paediatric charts. During the first visit, median serum levels of all studied hormones were statistically significant, and in most instances substantially, higher among Chinese women, who have a low incidence of breast cancer, compared with American women, who have a high incidence of breast cancer. An analogous pattern was evident during the second visit, although the relative differences tended to be smaller. Further research is needed to identify lifestyle or other exogenous determinants of pregnancy hormone levels, as well as possible mechanisms by which they may influence carcinogenic processes in the breast and possibly other organs.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adami, H-O, Adams, G., Boyle, P., Ewertz, M., Lee, N. C., Lund, E., Miller, A. B., Olsson, H., Steel, M., Trichopoulos, D. & Tulinius, H. (1990). Breast cancer etiology. Int J Cancer (suppl) 5: 22
Adami, H-O, Persson, I., Ekbom, A., Wolk, A., Ponten, J. & Trichopoulos, D. (1995). The aetiology and pathogenesis of human breast cancer. Mutat Res 333: 29–35.
Akre, O., Ekbom, A., Hsieh, C-C, Trichopoulos, D. & Adami, H-O (1996). Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst 88: 883–889.
Albanes, D. & Winick, M. (1988). Are cell number and cell proliferation risk factors for cancer?. J Natl Cancer Inst 80: 772–775.
Armitage, P. & Berry, G. (1987). Statistical Methods in Medical Research. Blackwell: Boston
Bakketeig, L. S., Magnus, P. & Sundet, J. M. (1991). In Differential development of health in a life-span perspective. Problems and Methods in Longitudinal Research: Stability and Change, Magnusson D, Bergman LR, Rudinger G, Torestad B (eds), pp. 95–106, Cambridge University Press: Cambridge
Barker, D. J. P. (1995). Fetal origins of coronary heart disease. Br Med J 311: 171–174.
Bernstein, L., Lipworth, L., Ross, R. K. & Trichopoulos, D. (1995). Correlation of estrogen levels between successive pregnancies. Am J Epidemiol 142: 625–628.
Cnattingius, S., Zack, M. M., Ekbom, A., Gunnarskog, J., Kreuger, A., Linet, M. & Adami, H-O (1995). Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 87: 908–914.
Cole, P. & MacMahon, B. (1969). Oestrogen fractions during early reproductive life in the aetiology of breast cancer. Lancet 1: 604–606.
deWaard, F. (1975). Breast cancer incidence and nutritional status with particular reference to body weight and weight. Cancer Res 35: 3351–3356.
Eby, N., Chang-Claude, J. & Bishop, D. T. (1994). Familial risk and genetic susceptibility for breast cancer. Cancer Causes Control 5: 458–470.
Ekbom, A., Thurfjell, E., Hsieh, C-C, Trichopoulos, D. & Adami, H-O (1995). Perinatal characteristics and adult mammographic patterns. Int J Cancer 61: 177
Ekbom, A., Hsieh, C-C, Lipworth, L., Wolk, A., Ponten, J., Adami, H-O & Trichopoulos, D. (1996). Perinatal characteristics in relation to incidence of and mortality from prostate cancer. Br Med J 313: 337–341.
Ekbom, A., Hsieh, C-C, Lipworth, L., Adami, H-O & Trichopoulos, D. (1997). Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 88: 71–76.
Falcone, T. & Little, A. B. (1994). Placental synthesis of steroid hormones. Maternal–Fetal Endocrinology, Tulchinsky D, Little AB (eds), pp. 1–14, Saunders: Philadelphia
Hsieh, C-C, Trichopoulos, D., Katsouyanni, K. & Yuasa, S. (1990). Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case–control study. Int J Cancer 46: 796–800.
Hunter, D. J., Spiegelman, D., Adami, H. O., Beeson, L., van den Brandt, P. A., Folsom, A. R., Fraser, G. E., Goldbohm, R. A., Graham, S., Howe, G. R., Kushi, L. H., Marshall, J. R., McDermott, A., Miller, A. B., Speizer, F. E., Wolk, A., Yuan, S-S & Willett, W. (1996). Cohort studies of fat intake and the risk of breast cancer – a pooled analysis. N Engl J Med 334: 356–361.
Hunter, D. J., Spiegelman, D., Adami, H-O, van den Brandt, P. A., Folsom, A. R., Goldbohm, R. A., Graham, S., Howe, G. R., Kushi, L. H., Marshall, J. R., Miller, A. B., Speizer, F. E., Willett, W., Wolk, A. & Yuan, S-S (1997). Non-dietary factors as risk factors for breast cancer, and as effect modifiers of the association of fat intake and risk of breast cancer. Cancer Causes Control 8: 49–56.
Kaye, S. A., Robison, L. L., Smithson, W. A., Gunderson, P., King, F. L. & Neglia, J. P. (1991). Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer 68: 1351–1355.
Kley, H. K. & Rick, W. (1984). Einfluβ von lagerung und temperatu auf die analyse von steroiden in plasma und blud. J Clin Chem Clin Biochem 22: 371–378.
Kley, H. K., Schlaghecke, R. & Kruskemper, H. L. (1985). Stabilitat von steroiden im plasma uber einen zeitraum von 10 jahren. J Clin Chem Clin Biochem 23: 875–878.
Lipworth, L. (1995). Epidemiology of breast cancer. Eur J Cancer Prev 4: 7–30.
Lipworth, L., Adami, H-O, Trichopoulos, D., Carlström, K. & Mantzoros, C. (1996). Serum steroid hormones, sex hormone-binding globulin and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 7: 96–100.
Michels, K. B., Trichopoulos, D., Robins, J. M., Rosner, B. A., Manson, J. E., Hunter, D. J., Colditz, G. A., Hankinson, S. E., Speizer, F. E. & Willett, W. C. (1996). Birthweight as a risk factor for breast cancer. Lancet 348: 1542–1546.
Murphy, B. E. P. & Branchaud, C. L. (1994). The fetal adrenal. In Maternal–Fetal Endocrinology, Tulchinsky D, Little AB (eds), pp. 275–295, Saunders: Philadelphia
Pegoraro, R. J., Nirmul, D., Reinach, S. G., Jordaan, J. P. & Joubert, S. M. (1986). Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status. Breast Cancer Res Treatment 7: 111–118.
Peto, J. (1989). Oral contraceptives and breast cancer: is the CASH study really negative?. Lancet 1: 552
Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, T. J. & Hoel, D. G. (1983). ‘Hormonal’ risk factors, ‘breast tissue age’, and the age-incidence of breast cancer. Nature 303: 767–770.
Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A. & Henderson, B. E. (1990). Increased cell division as a cause of human cancer. Cancer Res 50: 7415–7421.
Punnonen, R., Lukola, A. & Kudo, R. (1984). Cytoplasmic estrogen receptor concentrations in the endometrium of Finnish and Japanese women. Eur J Obstet Gynecol Reprod Biol 17: 321–325.
Rogers, A. E. & Longnecker, M. P. (1988). Dietary and nutritional influences on cancer: a review of epidemiologic and experimental data. Laboratory Invest 59: 729–759.
Russo, I. H. & Russo, J. (1996). Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104: 938–967.
Sanderson, M., Williams, M. A., Malone, K. E., Stanford, J. L., Emanuel, I., White, E. & Daling, J. R. (1996). Perinatal factors and risk of breast cancer. Epidemiology 7: 34–37.
Sandson, T. A., Wen, P. Y. & LeMay, M. (1992). Reversed cerebral asymmetry in women with breast cancer. Lancet 339: 523–524.
Sinnecker, G. (1989). Stability of sex-hormone-binding globulin in serum and plasma. Clin Chem 35: 1253–1254.
Tibblin, G., Eriksson, M., Cnattingius, S. & Ekbom, A. (1995). High birthweight as a predictor of prostate cancer risk. Epidemiology 6: 423–424.
Tomatis, L. (1989). Overview of perinatal and multi-generation carcinogenesis. Perinatal and Multigeneration Carcinogenesis, Napalkov NP, Rice JM, Tomatis L, Yamasaki H (eds), Vol. 96. pp. 1–15, IARC: Lyon
Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P. & Pasternack, B. S. (1995). A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87: 190–197.
Tretli, S. (1989). Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer 44: 23–30.
Trichopoulos, D. & Lipman, R. D. (1992). Mammary gland mass and breast cancer risk. Epidemiology 3: 523–526.
Trichopoulos, D. & Lipworth, L. (1995). Is cancer causation simpler than we thought, but more intractable?. Epidemiology 6: 347–349.
Valaoras, V., MacMahon, B., Trichopoulos, D. & Polychronopoulou, A. (1969). Lactation and reproductive histories of breast cancer patients in Greater Athens, 1965–67. Int J Cancer 4: 350–363.
van den Brandt, P. A., Dirx, M. J. M., Ronckers, C. M., van den Hoogen, P. & Goldbohm, R. A. (1997). Height, weight, weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Causes Control 8: 39–47.
Ziegler, R. G., Hoover, R. N., Pike, M. C., Hildesheim, A., Nomura, A. M. Y., West, D. W., Wu-Williams, A. H., Kolonel, L. N., Horn-Ross, P. L., Rosenthal, J. F. & Hyer, M. B. (1993). Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst 85: 1819–1827.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Lipworth, L., Hsieh, Cc., Wide, L. et al. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 79, 7–12 (1999). https://doi.org/10.1038/sj.bjc.6690003
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690003
Keywords
This article is cited by
-
Maternal and cord blood hormones in relation to birth size
European Journal of Epidemiology (2014)
-
Endocrine Disruptors and the Breast: Early Life Effects and Later Life Disease
Journal of Mammary Gland Biology and Neoplasia (2013)
-
Placental characteristics as a proxy measure of serum hormone and protein levels during pregnancy with a male fetus
Cancer Causes & Control (2011)
-
Energy intake during pregnancy in relation to offspring gender by maternal height
European Journal of Epidemiology (2011)
-
Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk
British Journal of Cancer (2009)
